EN
RU
Ertugliflozin L-Pyroglutamic Acid (CAS 1210344-83-4) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a highly selective SGLT2 inhibitor. By blocking renal glucose reabsorption, it delivers robust glycemic control, globally approved for type 2 diabetes mellitus treatment, fully meeting ICH, USP and EP pharmacopoeia quality standards.
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
APIsCNCAS Number :
1210344-83-4
Product categoriesGlobalEquipX is a professional platform dedicated to the global pharmaceutical industry,
Backed by strong industry expertise, one of our co-founders serves as a strategic advisor to leading pharmaceutical manufacturers and R&D companies in China, including HEC and Menovo, giving us unique insight into market trends and client needs.
With numerous pharmaceutical manufacturers sites, we always ensure consistent quality and sustainable supply.
With over 30 years of proven experiences in import and export in EXP/IMP, we deliver flexible cooperation models and comprehensive one-stop solutions covering API & Intermediate, chemicals, and equipment—helping our clients streamline sourcing and accelerate business growth.
We do hope to have the chance to supply you our sustainable qualified service.
| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
Ertugliflozin L-Pyroglutamic Acid (CAS 1210344-83-4) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a highly selective SGLT2 inhibitor. By blocking renal glucose reabsorption, it delivers robust glycemic control, globally approved for type 2 diabetes mellitus treatment, fully meeting ICH, USP and EP pharmacopoeia quality standards.
Our hours
Public Account
IPv6 network supported
Technical Articles
